Nebil A. Oumer

FDA investigator

Appears on 5 documents from 2012 to 2015, mostly at sites in Virginia. Most often cites production record review (21 CFR 211.192).

5
Documents on file
8.0
Observations per 483
2012
First seen
2015
Most recent

What they cite most

From 32 observations

Activity by year

2012: 1, 2013: 1, 2015: 3

Where

Virginia 3 · Maryland 2

Is Nebil A. Oumer coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Cape Apothecary Inc.Oct 7, 2015 · Annapolis, Maryland
Response Sentara Home Infusion Pharmacy ServicesAug 12, 2015 · Chesapeake, Virginia
483 Wood’s Pharmacy, Inc., dba The Medicine ShoppeJan 15, 2015 · Boones Mill, Virginia
483 Human Genome Sciences, Inc.Apr 26, 2013 · Rockville, Maryland
483 Merck Sharp & Dohme LLCAug 24, 2012 · Elkton, Virginia

About this profile

What does Nebil A. Oumer inspect?

Nebil A. Oumer appears on 5 documents on file covering 5 sites, mostly in Virginia.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.100 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Nebil A. Oumer is dated Oct 7, 2015.